19.09.2022
GENFIT, a late-stage biopharmaceutical company focussed on severe chronic liver diseases, has entered into an exclusivity agreement with a view to acquire all the share capital and voting rights of Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases.
31.08.2022
Did you already have a look at our infoletter from August? Among others with our “Climate & Energy Lunch”. Enjoy!
10.08.2022
The search for the most innovative cleantech startup for the Swisscom Startup Challenge is coming to an end. The selection committee has selected ten Swiss start-ups that will further contest to become one of the five winners. Loopia is one of them.
21.07.2022
Did you already have a look at our Infoletter from July? Among others with a review of our first “Sommerfäscht” at Technopark. Enjoy and happy holidays!
14.07.2022
With CHF 2.6 billion in venture capital and 163 financing rounds completed in the first half of 2022, Swiss start-ups once again set a record. However, an end to records is on the horizon: 60% of Swiss investors expect investment in Swiss start-ups to fall by up to 25% over the next 12 months.